Pharming Group (Netherlands) Investor Sentiment

PHARM Stock  EUR 0.83  0.02  2.35%   
About 61% of Pharming Group's investor base is looking to short. The analysis of current outlook of investing in Pharming Group NV suggests that many traders are alarmed regarding Pharming Group's prospects. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Pharming Group Sees Significant Decline in Short Interest - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Trading Report - Stock Traders Daily
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group reports third quarter 2023 financial results - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
iTeos Therapeutics, Inc. Stock Jumps 5.4 percent Will It Continue to Soar - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to report third quarter 2023 financial results on ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
ADRs Advance, Warrantee Inc. Climbs 20.0 percent - Morningstar
Google News at Macroaxis
over a year ago at news.google.com         
Pharvaris N Efficacy and safety of bradykinin B2 receptor antagonism with oral deucrictibant in prop...
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to convene Extraordinary General Meeting of Shareholders - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatmen...
Google News at Macroaxis
over a year ago at news.google.com         
Pharming to nominate industry leader Dr. Richard Peters as new ... - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to report second quarter and first half 2023 financial results on August 3 - Yahoo Fi...
Google News at Macroaxis
over a year ago at news.google.com         
Pharming announces sale of priority review voucher - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to attend the following Investor Conferences in June - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to attend the following Investor Conferences in ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Stock analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios